The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

by Plonis J, Kalniete D, Nakazawa-Miklasevica M, Irmejs A, Vjaters E, Gardovskis J, Miklasevics E
Published 2015-12-01